Matches in SemOpenAlex for { <https://semopenalex.org/work/W4303457465> ?p ?o ?g. }
- W4303457465 endingPage "46187" @default.
- W4303457465 startingPage "46176" @default.
- W4303457465 abstract "Hepatitis B virus (HBV) infection remains a major challenge to global health due to unsatisfactory treatment efficacy, side effects of current therapies, and immune tolerance. Toll-like receptors 7/8 (TLR7/8) agonists have shown great potential in chronic hepatitis B (CHB) cure, but systemic administration often induces severe side effects due to rapid dispersion into the microvasculature. Herein, we encapsulate an imidazoquinoline-based TLR7/8 agonist (IMDQ) into zeolitic imidazolate framework 8 nanoparticles (IMDQ@ZIF-8 NPs) for HBV immunotherapy. Compared with free IMDQ, IMDQ@ZIF-8 NPs efficiently accumulate in the liver and are selectively taken up by antigen-presenting cells (APCs), leading to enhanced APC activation and efficient viral elimination in HBV-infected models. Strikingly, MDQ@ZIF-8 NP treatment results in the obvious production of anti-HBs antibody and seroconversion in HBV-infected mice. Overall, this study on the convergence of a facile assembly approach and efficient therapeutic effects represents a promising strategy for HBV treatment." @default.
- W4303457465 created "2022-10-07" @default.
- W4303457465 creator A5003180731 @default.
- W4303457465 creator A5005395977 @default.
- W4303457465 creator A5014451075 @default.
- W4303457465 creator A5015996649 @default.
- W4303457465 creator A5019005101 @default.
- W4303457465 creator A5020186215 @default.
- W4303457465 creator A5027099198 @default.
- W4303457465 creator A5029577928 @default.
- W4303457465 creator A5041211306 @default.
- W4303457465 creator A5053203935 @default.
- W4303457465 creator A5053440938 @default.
- W4303457465 creator A5057129668 @default.
- W4303457465 creator A5069599527 @default.
- W4303457465 creator A5070081604 @default.
- W4303457465 creator A5089774868 @default.
- W4303457465 date "2022-10-07" @default.
- W4303457465 modified "2023-10-15" @default.
- W4303457465 title "Enhanced Delivery of TLR7/8 Agonists by Metal–Organic Frameworks for Hepatitis B Virus Cure" @default.
- W4303457465 cites W1978993716 @default.
- W4303457465 cites W1987376967 @default.
- W4303457465 cites W1995586746 @default.
- W4303457465 cites W2006774237 @default.
- W4303457465 cites W2008866474 @default.
- W4303457465 cites W2024801021 @default.
- W4303457465 cites W2027555120 @default.
- W4303457465 cites W2031263707 @default.
- W4303457465 cites W2052099238 @default.
- W4303457465 cites W2077215378 @default.
- W4303457465 cites W2144733364 @default.
- W4303457465 cites W2150259999 @default.
- W4303457465 cites W2337204897 @default.
- W4303457465 cites W2533513686 @default.
- W4303457465 cites W2573625758 @default.
- W4303457465 cites W2605785536 @default.
- W4303457465 cites W2774064974 @default.
- W4303457465 cites W2785853755 @default.
- W4303457465 cites W2789341035 @default.
- W4303457465 cites W2791064693 @default.
- W4303457465 cites W2801105435 @default.
- W4303457465 cites W2810505935 @default.
- W4303457465 cites W2895099366 @default.
- W4303457465 cites W2903208765 @default.
- W4303457465 cites W2903745537 @default.
- W4303457465 cites W2908532599 @default.
- W4303457465 cites W2917632841 @default.
- W4303457465 cites W2920362394 @default.
- W4303457465 cites W2921274641 @default.
- W4303457465 cites W2926729059 @default.
- W4303457465 cites W2936176039 @default.
- W4303457465 cites W2945693882 @default.
- W4303457465 cites W2953372515 @default.
- W4303457465 cites W2969215204 @default.
- W4303457465 cites W2978759762 @default.
- W4303457465 cites W2979893011 @default.
- W4303457465 cites W2993156910 @default.
- W4303457465 cites W3010107438 @default.
- W4303457465 cites W3010530314 @default.
- W4303457465 cites W3015704148 @default.
- W4303457465 cites W3033883459 @default.
- W4303457465 cites W3046237829 @default.
- W4303457465 cites W3048245695 @default.
- W4303457465 cites W3093332436 @default.
- W4303457465 cites W3112011385 @default.
- W4303457465 cites W3128523953 @default.
- W4303457465 cites W3135498264 @default.
- W4303457465 cites W3135786616 @default.
- W4303457465 cites W3137090375 @default.
- W4303457465 cites W3174558322 @default.
- W4303457465 doi "https://doi.org/10.1021/acsami.2c11203" @default.
- W4303457465 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36206454" @default.
- W4303457465 hasPublicationYear "2022" @default.
- W4303457465 type Work @default.
- W4303457465 citedByCount "1" @default.
- W4303457465 countsByYear W43034574652023 @default.
- W4303457465 crossrefType "journal-article" @default.
- W4303457465 hasAuthorship W4303457465A5003180731 @default.
- W4303457465 hasAuthorship W4303457465A5005395977 @default.
- W4303457465 hasAuthorship W4303457465A5014451075 @default.
- W4303457465 hasAuthorship W4303457465A5015996649 @default.
- W4303457465 hasAuthorship W4303457465A5019005101 @default.
- W4303457465 hasAuthorship W4303457465A5020186215 @default.
- W4303457465 hasAuthorship W4303457465A5027099198 @default.
- W4303457465 hasAuthorship W4303457465A5029577928 @default.
- W4303457465 hasAuthorship W4303457465A5041211306 @default.
- W4303457465 hasAuthorship W4303457465A5053203935 @default.
- W4303457465 hasAuthorship W4303457465A5053440938 @default.
- W4303457465 hasAuthorship W4303457465A5057129668 @default.
- W4303457465 hasAuthorship W4303457465A5069599527 @default.
- W4303457465 hasAuthorship W4303457465A5070081604 @default.
- W4303457465 hasAuthorship W4303457465A5089774868 @default.
- W4303457465 hasConcept C136449434 @default.
- W4303457465 hasConcept C159047783 @default.
- W4303457465 hasConcept C192562407 @default.
- W4303457465 hasConcept C203014093 @default.
- W4303457465 hasConcept C2522874641 @default.
- W4303457465 hasConcept C2776709828 @default.